Literature DB >> 20556377

Vkappa polymorphisms in NOD mice are spread throughout the entire immunoglobulin kappa locus and are shared by other autoimmune strains.

Rachel A Henry1, Peggy L Kendall, Emily J Woodward, Chrys Hulbert, James W Thomas.   

Abstract

The diversity of immunoglobulin (Ig) and T cell receptor (TCR) genes available to form the lymphocyte repertoire has the capacity to produce a broad array of both protective and harmful specificities. In type 1 diabetes (T1D), the presence of antibodies to insulin and other islet antigens predicts disease development in both mice and humans, and demonstrate that immune tolerance is lost early in the disease process. Anti-insulin T cells isolated from T1D-prone non-obese diabetic (NOD) mice use polymorphic TCRalpha chains, suggesting that the available T cell repertoire is altered in these autoimmune mice. To probe whether insulin-binding B cells also possess polymorphic V genes, Ig light chains were isolated and sequenced from NOD mice that harbor an Ig heavy chain transgene. Three insulin-binding Vkappa genes were identified, all of which were polymorphic to the closest germline sequence matches present in the GenBank database. Additional analysis of over 300 light chain sequences from multiple sources, including germline DNA, shows that polymorphisms are spread throughout the entire NOD Igkappa locus, as these polymorphic sequences represent 43 distinct Vkappa genes which belong to 14 Vkappa families. Database searches reveal that a majority of polymorphic Vkappa genes identified in NOD are identical to Vkappa genes isolated from SLE-prone NZBxNZW F1 or MRL strains of mice, suggesting that a shared Igkappa haplotype may be present. Predicted amino acid changes preferentially occur in CDR, and thus could alter antigen recognition by the germline B cell repertoire of autoimmune versus non-autoimmune mouse strains.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556377      PMCID: PMC2970566          DOI: 10.1007/s00251-010-0457-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  17 in total

1.  Somatically mutated B cell pool provides precursors for insulin antibodies.

Authors:  J W Thomas; C Hulbert
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

2.  New alleles of IGKV genes A2 and A18 suggest significant human IGKV locus polymorphism.

Authors:  M J Atkinson; M J Cowan; A J Feeney
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

3.  T cell receptor gene polymorphisms associated with anti-insulin, autoimmune T cells in diabetes-prone NOD mice.

Authors:  E A Simone; L Yu; D R Wegmann; G S Eisenbarth
Journal:  J Autoimmun       Date:  1997-06       Impact factor: 7.094

4.  T cell-independent response to Brucella-insulin identifies a preimmune repertoire for insulin.

Authors:  J W Thomas; P M Kralick; U K Ewulonu
Journal:  J Immunol       Date:  1997-09-01       Impact factor: 5.422

5.  B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice.

Authors:  C Hulbert; B Riseili; M Rojas; J W Thomas
Journal:  J Immunol       Date:  2001-11-15       Impact factor: 5.422

6.  Complexity, polymorphism, and connectivity of mouse Vk gene families.

Authors:  R Kofler; M A Duchosal; F J Dixon
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

7.  T cell receptor restriction of diabetogenic autoimmune NOD T cells.

Authors:  E Simone; D Daniel; N Schloot; P Gottlieb; S Babu; E Kawasaki; D Wegmann; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

8.  The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.

Authors:  Pablo A Silveira; Ellis Johnson; Harold D Chapman; Thi Bui; Roland M Tisch; David V Serreze
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

9.  T cell islet accumulation in type 1 diabetes is a tightly regulated, cell-autonomous event.

Authors:  Greig P Lennon; Maria Bettini; Amanda R Burton; Erica Vincent; Paula Y Arnold; Pere Santamaria; Dario A A Vignali
Journal:  Immunity       Date:  2009-10-08       Impact factor: 31.745

10.  A defective Vkappa A2 allele in Navajos which may play a role in increased susceptibility to haemophilus influenzae type b disease.

Authors:  A J Feeney; M J Atkinson; M J Cowan; G Escuro; G Lugo
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

View more
  11 in total

1.  Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.

Authors:  James B Case; Rachel H Bonami; Lindsay E Nyhoff; Hannah E Steinberg; Allison M Sullivan; Peggy L Kendall
Journal:  J Immunol       Date:  2015-06-01       Impact factor: 5.422

2.  CXCL13 blockade disrupts B lymphocyte organization in tertiary lymphoid structures without altering B cell receptor bias or preventing diabetes in nonobese diabetic mice.

Authors:  Rachel A Henry; Peggy L Kendall
Journal:  J Immunol       Date:  2010-06-23       Impact factor: 5.422

3.  Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.

Authors:  Rachel H Bonami; James W Thomas
Journal:  J Immunol       Date:  2015-10-02       Impact factor: 5.422

4.  Reversing Tolerance in Isotype Switch-Competent Anti-Insulin B Lymphocytes.

Authors:  Jonathan M Williams; Rachel H Bonami; Chrys Hulbert; James W Thomas
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

5.  Regulation of basement membrane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice.

Authors:  Amy G Clark; Qihua Fan; Graham F Brady; Katherine M Mackin; Evan D Coffman; Melissa L Weston; Mary H Foster
Journal:  Autoimmunity       Date:  2013-01-09       Impact factor: 2.815

6.  B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice.

Authors:  Rachel A Henry-Bonami; Jonathan M Williams; Amita B Rachakonda; Mariam Karamali; Peggy L Kendall; James W Thomas
Journal:  J Immunol       Date:  2013-05-15       Impact factor: 5.422

7.  Autoantigen-specific B-cell depletion overcomes failed immune tolerance in type 1 diabetes.

Authors:  Rachel A Henry; Peggy L Kendall; James W Thomas
Journal:  Diabetes       Date:  2012-06-14       Impact factor: 9.461

8.  New Players in the Field of T1D: Anti-Peripherin B Lymphocytes.

Authors:  Peggy L Kendall
Journal:  Diabetes       Date:  2016-07       Impact factor: 9.461

9.  Class-switched anti-insulin antibodies originate from unconventional antigen presentation in multiple lymphoid sites.

Authors:  Xiaoxiao Wan; James W Thomas; Emil R Unanue
Journal:  J Exp Med       Date:  2016-05-02       Impact factor: 14.307

Review 10.  Immunoglobulin Light Chain Gene Rearrangements, Receptor Editing and the Development of a Self-Tolerant Antibody Repertoire.

Authors:  Andrew M Collins; Corey T Watson
Journal:  Front Immunol       Date:  2018-10-08       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.